Enhancing RNA inhibitory activity using clamp-G-modified nucleobases

SP Pradeep, V Kumar, S Malik, FJ Slack… - Cell Reports Physical …, 2024 - cell.com
We explore the potential of clamp-G nucleobase-modified peptide nucleic acids (cGPNAs)
as microRNA and messenger RNA inhibitors. For proof of concept, we target miR-155, which …

Transcription Factors in Prostate Cancer: Insights for Disease Development and Diagnostic and Therapeutic Approaches

KCS Silva, N Tambwe, DH Mahfouz, M Wium… - Genes, 2024 - mdpi.com
Transcription factors (TFs) are proteins essential for the regulation of gene expression, and
they regulate the genes involved in different cellular processes, such as proliferation …

Evolution of antisense oligonucleotides: navigating nucleic acid chemistry and delivery challenges

R Ruchi, GM Raman, V Kumar… - Expert Opinion on Drug …, 2025 - Taylor & Francis
Introduction Antisense oligonucleotide (ASO) was established as a viable therapeutic option
for genetic disorders. ASOs can target RNAs implicated in various diseases, including …

Exploring the therapeutic potential of sγPNA-141: Pharmacodynamics and mechanistic insights during ischemic stroke recovery

SK Yadav, K Dhuri, D Gamiotea-Turro… - … Therapy Nucleic Acids, 2024 - cell.com
MicroRNA-141-3p plays a detrimental role in the pathology of ischemic stroke, presenting a
new target for stroke treatment. This study introduces and validates a novel class of peptide …

Bulk and single-cell transcriptome revealed the metabolic heterogeneity in human glioma

Y Xiao, M Zhao, R Wang, L Liu, C Xiang, T Li, C Qian… - Heliyon, 2024 - cell.com
Background Emerging perspectives on tumor metabolism reveal its heterogeneity, a
characteristic yet to be fully explored in gliomas. To advance therapies targeting metabolic …

Double-stranded DNA invasion by anti-gene oligonucleotide clamps

A De, R Bahal - Molecular Therapy Nucleic Acids, 2024 - cell.com
Umek et al. reported a promising AGO with a clamp design to target the doublestranded
DNA (dsDNA). Umek et al. designed a series of mixmers made of locked nucleic acid (LNA) …

Advancements in cell-penetrating monoclonal antibody treatment

SP Pradeep, R Bahal - Oncotarget, 2024 - pmc.ncbi.nlm.nih.gov
Advancements in cell-penetrating monoclonal antibody treatment - PMC Skip to main content
Here's how you know Official websites use .gov A .gov website belongs to an official government …